Construction of an oral squamous cell carcinoma cell line for stable PA28γ overexpression

doi:10.7518/hxkq.2020.01.002

Abstract

Abstract:

Objective To construct a PA28γ overexpression cell line and determine its effects after infecting an oral squamous cell carcinoma (OSCC) cell line. Methods The PA28γ gene was cloned into the pLOV.CMV.cherry.2A.EF1a.PuroR lentiviral vector by polymerase chain reaction (PCR), and PCR and DNA sequencing alignment analysis were used for identification. Then, 293T cells were used to package viral diseases. Infected OSCC cells were used to construct a cell line with stable PA28γ overexpression. Finally, the level of PA28γ expression in the OSCC cell line was detected through Western blot. Results The successful construction of PA28γ recombinant lentiviral vectors was confirmed by DNA sequencing. The results of immunofluorescence showed that the PA28γ overexpression lentivirus successfully infected the OSCC cells and showed cherry red fluorescence. The results of Western blot demonstrated that the constructed cells with stable PA28γ overexpression significantly increased the expression of PA28γ. Conclusion The PA28γ overexpression lentiviral vector can significantly increase its protein expression in OSCC cells. We provide a stable OSCC cell line for further study on the effect of PA28γ in OSCC.

Key words: oral squamous cell carcinoma, PA28γ, lentivirus, overexpression vector, stable overexpression cell line

CLC Number:

Q782

Xin Chuan,Wang Jiongke,Li Jing,Zeng Xin. Construction of an oral squamous cell carcinoma cell line for stable PA28γ overexpression[J]. West China Journal of Stomatology, 2020, 38(1): 6-10.

Figures/Tables 4

References 18

[1]	Kontos CK . Surrogate prognostic biomarkers in OSCC: the paradigm of PA28γ overexpression[J]. EBioMedicine, 2015,2(8):784-785.
[2]	Bray F, Ferlay J, Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424.
[3]	Bray F, Jemal A, Grey N , et al. Global cancer transitions according to the Human Development Index (2008—2030): a population-based study[J]. Lancet Oncol, 2012,13(8):790-801.
[4]	Panzarella V, Pizzo G, Calvino F , et al. Diagnostic delay in oral squamous cell carcinoma: the role of cognitive and psychological variables[J]. Int J Oral Sci, 2014,6(1):39-45.
[5]	李高飞, 覃世逆, 徐伟文 . 蛋白酶体激活因子PA28γ与肿瘤相关研究进展[J]. 分子诊断与治疗杂志, 2012,4(5):356-360.
	Li GF, Qin SN, Xu WW . Research progress in the relationship between proteasome activator PA28γ and cancer[J]. J Mol Diagn Ther, 2012,4(5):356-360.
[6]	Xu X, Liu D, Ji N , et al. A novel transcript variant of proteasome activator 28γ: identification and function in oral cancer cells[J]. Int J Oncol, 2015,47(1):188-194.
[7]	Chen SJ, Wang QW, Wang LS , et al. REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma[J]. Cell Death Dis, 2018,9(6):627.
[8]	Li L, Dang YY, Zhang JS , et al. REGγ is critical for skin carcinogenesis by modulating the Wnt/β-catenin pathway[J]. Nat Commun, 2015,6:6875.
[9]	Li J, Feng X, Sun C , et al. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: evidence from cohort studies and functional analyses[J]. EBioMedicine, 2015,2(8):851-858.
[10]	王韵, 吉宁, 周敏 , 等. microRNA-223过表达与抑制表达慢病毒载体的构建及鉴定[J]. 华西口腔医学杂志, 2015,33(5):451-455.
	Wang Y, Ji N, Zhou M , et al. Construction and identification of recombinant lentivirus vector for microRNA-223 overexpression and suppression[J]. West China J Stomatol, 2015,33(5):451-455.
[11]	Moncsek A, Gruner M, Meyer H , et al. Evidence for anti-apoptotic roles of proteasome activator 28γ via inhibiting caspase activity[J]. Apoptosis, 2015,20(9):1211-1228.
[12]	Barton LF, Runnels HA, Schell TD , et al. Immune defects in 28-kDa proteasome activator gamma-deficient mice[J]. J Immunol, 2004,172(6):3948-3954.
[13]	Sun L, Fan G, Shan P , et al. Regulation of energy homeostasis by the ubiquitin-independent REGγ proteasome[J]. Nat Commun, 2016,7:12497.
[14]	Huang L, Haratake K, Miyahara H , et al. Proteasome activators, PA28γ and PA200, play indispensable roles in male fertility[J]. Sci Rep, 2016,6:23171.
[15]	Wang H, Bao W, Jiang F , et al. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ[J]. Cancer Lett, 2015,360(2):269-279.
[16]	Levy-Barda A, Lerenthal Y, Davis AJ , et al. Involvement of the nuclear proteasome activator PA28γ in the cellular response to DNA double-strand breaks[J]. Cell Cycle, 2011,10(24):4300-4310.
[17]	Li X, Lonard DM, Jung SY , et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome[J]. Cell, 2006,124(2):381-392.
[18]	Chen X, Barton LF, Chi Y , et al. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome[J]. Mol Cell, 2007,26(6):843-852.